ASKP3 Annual Conference 2026

The American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) will hold its Annual Conference from 29–31 January 2026 in Austin, Texas. As the flagship event for the society, the ASKP3 conference is dedicated to the safe and ethical use of ketamine and related therapeutic modalities. The gathering serves a diverse audience of medical doctors, psychotherapists, and advanced practice providers committed to excellence in the ketamine-assisted therapy field.

The conference programme includes a mixture of scientific lectures, clinical workshops, and sessions on practice management. Topics typically range from the neurobiology of ketamine’s therapeutic effects to the integration of psychotherapy and the navigation of the current regulatory environment. By providing a platform for the exchange of clinical experiences and research data, the event plays a crucial role in establishing professional standards and best practices for the industry.

In addition to the formal education sessions, the conference emphasizes the importance of community and ethical collaboration among practitioners. The Austin venue provides an interactive setting for networking and the formation of professional partnerships. ASKP3 2026 remains a cornerstone event for those seeking to provide high-quality, patient-centred care in the expanding field of ketamine and psychedelic-assisted medicine.